These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8868942)

  • 21. Primary myeloid leukemia presenting concomitantly with primary multiple myeloma: two cases and an update of the literature.
    Anderson CM; Bueso-Ramos CE; Wallner SA; Albitar M; Rosenzweig TE; Koller CA
    Leuk Lymphoma; 1999 Jan; 32(3-4):385-90. PubMed ID: 10037039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neuromeningeal involvement in myelodysplastic syndromes. 1st referred case].
    Avilés A; Gómez J; Murillo E; González-Llavén J
    Sangre (Barc); 1988 Jun; 33(3):239. PubMed ID: 3175822
    [No Abstract]   [Full Text] [Related]  

  • 23. Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients with AML, secondary AML, and refractory anemia with excess blasts in transformation.
    Saito K; Nakamura Y; Aoyagi M; Waga K; Yamamoto K; Aoyagi A; Inoue F; Nakamura Y; Arai Y; Tadokoro J; Handa T; Tsurumi S; Arai H; Kawagoe Y; Gunnji H; Kitsukawa Y; Takahashi W; Furusawa S
    Int J Hematol; 2000 Apr; 71(3):238-44. PubMed ID: 10846828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular extramedullary myeloid cell tumour in children: an Indian study.
    Gujral S; Bhattarai S; Mohan A; Jain Y; Arya LS; Ghose S; Singha U; Kumar R
    J Trop Pediatr; 1999 Apr; 45(2):112-5. PubMed ID: 10341509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Unexpected Innocent Complication Associated with Azacitidine Treatment of Myelodysplastic Syndrome: Erythema Annulare Centrifugum.
    Turan Erkek E; Kalayoğlu Beşışık S
    Turk J Haematol; 2016 Mar; 33(1):81-2. PubMed ID: 27020727
    [No Abstract]   [Full Text] [Related]  

  • 26. [Refractory anemia with excess of blasts (RAEB) with a high level of HbF that preceded apparent pancytopenia].
    Matsuda A; Kusumoto S; Ito K; Yokoo H; Maruyama T; Jinnai I; Harano T; Watanabe K; Hirashima K
    Rinsho Ketsueki; 1996 Jan; 37(1):60-4. PubMed ID: 8683869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study.
    Hasserjian RP; Campigotto F; Klepeis V; Fu B; Wang SA; Bueso-Ramos C; Cascio MJ; Rogers HJ; Hsi ED; Soderquist C; Bagg A; Yan J; Ochs R; Orazi A; Moore F; Mahmoud A; George TI; Foucar K; Odem J; Booth C; Morice W; DeAngelo DJ; Steensma D; Stone RM; Neuberg D; Arber DA
    Am J Hematol; 2014 Nov; 89(11):E193-9. PubMed ID: 25042343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of monocytic leukaemia cutis in a patient with myelodysplastic syndrome transforming to acute myeloid leukaemia.
    Perez A; Kennedy C; Standen G; Oxley J
    Clin Exp Dermatol; 2004 Sep; 29(5):497-8. PubMed ID: 15347335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined low-dose cytarabine, melphalan and mitoxantrone for older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome.
    Yamauchi T; Negoro E; Arai H; Ikegaya S; Takagi K; Takemura H; Inai K; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
    Anticancer Res; 2007; 27(4C):2635-9. PubMed ID: 17695426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A remarkable effect of K-18 (IgG-melphalan complex) in a case of RAEB with hypoplastic marrow].
    Fujikawa K; Mogi Y; Ito K; Tsushima N; Saito T; Ishigaki S; Watanabe N; Kohgo Y; Mikami T; Niitsu Y
    Gan To Kagaku Ryoho; 1991 Feb; 18(2):287-91. PubMed ID: 1992922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Empirical examination of the neutrophil criterion (>1500 microl(-1)) currently needed to declare CR in AML.
    Estey E; Giles F; Cortes J; Beran M; Verstovsek S; Garcia-Manero G; Faderl S; Kantarjian H
    Leuk Res; 2003 Jun; 27(6):475-9. PubMed ID: 12648505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The simultaneous diagnosis of Kaposi sarcoma and MDS RAEB-II in a human immunodeficiency virus-negative patient. A rare occurrence.
    Pamuk GE; Aydogdu E; Turgut B; Demir M
    Ann Hematol; 2009 Apr; 88(4):389-91. PubMed ID: 18726594
    [No Abstract]   [Full Text] [Related]  

  • 33. No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: better outcome in patients with less proliferative disease.
    Hast R; Hellström-Lindberg E; Ohm L; Björkholm M; Celsing F; Dahl IM; Dybedal I; Gahrton G; Lindberg G; Lerner R; Linder O; Löfvenberg E; Nilsson-Ehle H; Paul C; Samuelsson J; Tangen JM; Tidefelt U; Turesson I; Wahlin A; Wallvik J; Winquist I; Oberg G; Bernell P
    Leukemia; 2003 Sep; 17(9):1827-33. PubMed ID: 12970783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients With a History of Chemotherapy and Isolated del(20q) With Minimal Myelodysplasia Have an Indolent Course.
    Courville EL; Singh C; Yohe S; Linden MA; Naemi K; Berger M; Ustun C; McKenna RW; Dolan M
    Am J Clin Pathol; 2016 Apr; 145(4):459-66. PubMed ID: 27124938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FLAGIDA-lite is an effective regimen for patients between 70 and 80 years with acute myeloid leukemia or refractory anemia with excess blasts-2 and is feasible as outpatient treatment.
    Bermúdez A; Pérez-Vázquez G; Insunza A; Baro J; Colorado M; Conde E; Díez-Gallarreta Z; Gutiérrez ML; López-Duarte M; Olalla I; Sanroma P; Yañez L; Iriondo A; Richard C
    Am J Hematol; 2012 Jan; 87(1):42-4. PubMed ID: 22015963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myelodysplastic syndrome presenting as sarcoidosis.
    Defilipp Z; Brice J; Wasko MC; Lister J
    Int J Rheum Dis; 2013 Jun; 16(3):371-2. PubMed ID: 23981766
    [No Abstract]   [Full Text] [Related]  

  • 37. [Refractory anemia with excess myeloblast in transformation induced remission by combined oral administration of cytarabine ocfosfate and 6-mercaptopurine].
    Fukumi S; Mizorogi F; Matsuo A; Sato H; Abe T
    Gan To Kagaku Ryoho; 1995 Jun; 22(7):945-8. PubMed ID: 7794001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Poor response in patients with de novo acute myeloid leukemia and erythroblastic or megakaryocytic dysplasia to treatment with standard doses of cytosine arabinoside and daunorubicin].
    Lemez P; Gáliková J; Haas T
    Vnitr Lek; 1999 Jun; 45(6):342-6. PubMed ID: 11045169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II trial of CPT-11 in myelodysplastic syndromes with excess of marrow blasts.
    Ribrag V; Suzan F; Ravoet C; Feremans W; Guerci A; Dreyfus F; Damaj G; Vantelon JM; Bourhis JH; Fenaux P
    Leukemia; 2003 Feb; 17(2):319-22. PubMed ID: 12592329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FLAG-IDA in the treatment of refractory/relapsed acute leukaemias: single centre study.
    Hashmi KU; Khan B; Ahmed P; Raza S; Hussain I; Mahmood A; Iqbal H; Malik HS; Anwar M
    J Pak Med Assoc; 2005 Jun; 55(6):234-8. PubMed ID: 16045091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.